基于网络药理学,分子对接和分子动力学模拟的基础上,Bugantang对肝纤维化减轻作用的机制
Taojing Zhang1, Jia Chang1, Zengle Zheng1
1School of Life Sciences, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Current computer-aided drug design
|December 3, 2024
概括
布甘 (BGT) 通过与关键化合物和标相互作用,显示出治疗肝纤维化的潜力. 这项研究验证了BGT的有效性.
科学领域:
- 传统中国医药 传统中国医药
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 肝纤维化是一种严重的慢性疾病,缺乏有效的治疗方法.
- 布甘 (BGT) 是一种传统的中国草药处方,它对肝纤维化有好处.
- 对于肝纤维化BGT的精确疗效和机制需要进一步研究.
研究的目的:
- 评估BGT在治疗肝纤维化的疗效.
- 为了确定BGT的活性化合物和关键标.
- 阐明BGT在肝纤维化中的作用的潜在机制.
主要方法:
- 利用CCL4诱导的小鼠模型进行肝纤维化评估.
- 综合生物信息数据库 (HERB,TCMSP,DisGeNET,GEO,GeneCards) 用于识别BGT化合物和肝纤维化位.
- 进行了网络分析,KEGG/GO丰富,分子对接和分子动力学模拟.
主要成果:
- 在BGT中确定了215个目标和152个活性化合物.
- 关键化合物包括甲醇,氨酸和β-氨酸;关键标包括AKT1,MMP9和TNF.
- BGT的治疗作用涉及PI3K-AKT和MAPK信号通路,亡和炎症,稳定的分子相互作用得到证实.
结论:
- BGT在治疗肝纤维化的潜力源于其多样化的活性化合物,标和途径.
- 这些发现支持BGT在肝纤维化的临床应用.
- 这项研究为开发基于BGT的新型抗纤维菌候选药物提供了基础.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
496
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
1.9K
相关概念视频
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
26
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
26
01:26Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K